Alzheimer’s disease is one of the most feared illnesses of old age. It slowly damages memory, thinking, and the ability to carry out everyday activities.
Around the world, millions of people live with Alzheimer’s, and the number is expected to grow as populations age.
Despite decades of research, scientists still do not have a cure, and many treatments can only provide limited relief from symptoms. This is why researchers continue searching for new ways to understand what causes the disease and how it might be stopped.
Now, scientists at the University of Virginia School of Medicine have uncovered an important clue that could lead to a completely new approach to treating Alzheimer’s disease and other brain disorders.
The discovery centers on a molecule called STING, which stands for Stimulator of Interferon Genes. Under normal conditions, STING plays an important role in the immune system. It helps the body detect infections, fight viruses, and remove damaged cells. In a healthy body, this response helps protect tissues and supports overall health.
However, the new research suggests that STING may become harmful when it is overly active in the brain. Instead of protecting brain tissue, excessive STING activity appears to trigger chronic inflammation, which can damage brain cells over time.
Inflammation is a natural defense mechanism. When the body is injured or infected, inflammation helps the immune system respond to the threat. But when inflammation becomes long-lasting, it can begin to harm healthy tissue.
Scientists have increasingly linked chronic inflammation to many diseases associated with aging, including Alzheimer’s disease.
The research team, led by Dr. John Lukens, discovered that excessive STING activity appears to accelerate two of the most well-known features of Alzheimer’s disease. One is the buildup of amyloid plaques, which are sticky protein clumps that collect between brain cells.
The other is the formation of tau tangles, twisted fibers that develop inside brain cells. Both plaques and tangles are considered major signs of Alzheimer’s and are closely linked to the loss of memory and thinking ability.
To better understand STING’s role, the researchers conducted experiments using mice that developed Alzheimer’s-like symptoms. They tested what would happen if STING activity was blocked. The results were encouraging.
When STING was suppressed, the mice showed less brain damage and better protection of important brain cells. The researchers also observed changes in microglia, which are specialized immune cells that live in the brain.
These cells normally help keep the brain healthy by clearing away waste and responding to injury. However, in Alzheimer’s disease, microglia can become overactive and contribute to inflammation.
The study found that blocking STING reduced the harmful activity of microglia around amyloid plaques. As a result, nearby brain cells were better protected from damage. Even more importantly, the mice performed better on memory tests, suggesting that their brains were functioning more normally.
These findings are especially exciting because most current Alzheimer’s treatments focus mainly on either amyloid plaques or tau tangles. STING appears to influence both processes through its effects on inflammation. This means that treatments targeting STING could potentially address multiple aspects of the disease at the same time.
Researchers also believe that STING may play a role throughout different stages of Alzheimer’s disease. If this proves true in future studies, therapies targeting STING could have broader benefits than treatments aimed at only one specific disease feature.
Jessica Thanos, one of the study’s researchers, emphasized the importance of understanding how the brain’s immune system changes with age. Scientists now recognize that immune activity in the brain plays a major role in both healthy aging and disease.
By learning more about the causes of harmful inflammation, researchers hope to develop treatments that can prevent brain damage before significant memory loss occurs.
Although the results are promising, the research is still at an early stage. The study was conducted in laboratory mice, and scientists must now determine whether similar effects occur in humans.
Researchers also need to carefully evaluate the safety of blocking STING because the molecule serves important functions elsewhere in the body. Completely shutting down STING could potentially weaken the immune system’s ability to fight infections or detect cancer cells.
The work was carried out at the Harrison Family Translational Research Center, part of the Paul and Diane Manning Institute of Biotechnology at the University of Virginia. Dr. Lukens and his team hope their findings will open the door to safer and more effective treatments for Alzheimer’s disease and other conditions involving brain inflammation.
The study highlights a growing shift in Alzheimer’s research. Instead of focusing only on plaques and tangles, scientists are increasingly examining the role of the immune system and chronic inflammation. This broader understanding may reveal new ways to slow, prevent, or even stop the disease before serious damage occurs.
The research offers fresh hope that targeting harmful immune responses could one day help protect memory, preserve brain function, and improve the lives of millions of people affected by Alzheimer’s disease.
Copyright © 2026 Knowridge Science Report. All rights reserved.
